Literature DB >> 1980611

Effects of anticholinergic medication on memory in schizophrenia.

M E Strauss1, K S Reynolds, G Jayaram, L E Tune.   

Abstract

Verbal memory and reaction time of ten schizophrenic patients were compared at two different serum anticholinergic levels. Verbal recall was worse at higher drug levels, while reaction time tended to be improved by anticholinergic treatment. Implications for studies of memory in schizophrenia are considered.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1980611     DOI: 10.1016/0920-9964(90)90045-9

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  21 in total

Review 1.  Pharmacological treatment of psychosis and agitation in elderly patients with dementia: four decades of experience.

Authors:  Sandra S Kindermann; Christian R Dolder; Anne Bailey; Ira R Katz; Dilip V Jeste
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

2.  Deficient maturation of aspects of attention and executive functions in early onset schizophrenia.

Authors:  Jens Richardt M Jepsen; Birgitte Fagerlund; Anne Katrine Pagsberg; Anne Marie R Christensen; Merete Nordentoft; Erik L Mortensen
Journal:  Eur Child Adolesc Psychiatry       Date:  2010-08-01       Impact factor: 4.785

Review 3.  Pharmacological approaches to the management of cognitive dysfunction in schizophrenia.

Authors:  Philip D Harvey; Margaret M McClure
Journal:  Drugs       Date:  2006       Impact factor: 9.546

Review 4.  The SOHO (Schizophrenia Outpatient Health Outcome) study: implications for the treatment of schizophrenia.

Authors:  Josep Maria Haro; Luis Salvador-Carulla
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

5.  The Impact of Anticholinergic Burden on Functional Capacity in Persons With Schizophrenia Across the Adult Life Span.

Authors:  Waqas Ullah Khan; Zaid Ghazala; Heather Jane Brooks; Ponnusamy Subramaniam; Benoit H Mulsant; Sanjeev Kumar; Aristotle N Voineskos; Daniel M Blumberger; Robert S Kern; Tarek K Rajji
Journal:  Schizophr Bull       Date:  2021-01-23       Impact factor: 9.306

Review 6.  [Treatment of cognitive deficits in schizophrenia. Part 2: Pharmacological strategies].

Authors:  D Roesch-Ely; U Pfueller; C Mundt; U Müller; M Weisbrod
Journal:  Nervenarzt       Date:  2010-05       Impact factor: 1.214

Review 7.  Clinically significant interactions of psychotropic agents with antipsychotic drugs.

Authors:  M C Meyer; R J Baldessarini; D C Goff; F Centorrino
Journal:  Drug Saf       Date:  1996-11       Impact factor: 5.606

8.  Course of intelligence deficits in early onset, first episode schizophrenia: a controlled, 5-year longitudinal study.

Authors:  Jens Richardt Moellegaard Jepsen; Birgitte Fagerlund; Anne Katrine Pagsberg; Anne Marie R Christensen; Rikke W Hilker; Merete Nordentoft; Erik L Mortensen
Journal:  Eur Child Adolesc Psychiatry       Date:  2009-09-10       Impact factor: 4.785

9.  The cognitive cost of anticholinergic burden: decreased response to cognitive training in schizophrenia.

Authors:  Sophia Vinogradov; Melissa Fisher; Heather Warm; Christine Holland; Margaret A Kirshner; Bruce G Pollock
Journal:  Am J Psychiatry       Date:  2009-07-01       Impact factor: 18.112

10.  Cognition and functional outcome among deaf and hearing people with schizophrenia.

Authors:  Heather K Horton; Steven M Silverstein
Journal:  Schizophr Res       Date:  2007-06-07       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.